×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
Yahoo Finance
SEATTLE, WA / ACCESSWIRE / April 15, 2024 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on...
3 days ago
Why Is Aptevo Therapeutics (APVO) Stock Down 56% Today?
InvestorPlace
Aptevo Therapeutics stock is falling on Thursday after the company priced a public offering for 3.4 million shares of APVO.
1 week ago
StockNews.com Begins Coverage on Aptevo Therapeutics (NASDAQ:APVO)
Defense World
Stock analysts at StockNews.com assumed coverage on shares of Aptevo Therapeutics (NASDAQ:APVO – Get Free Report) in a report issued on...
1 day ago
Form 424B4 Aptevo Therapeutics Inc.
StreetInsider
926,666 Shares of Common Stock. 2,473,334 Pre-funded Warrants to Purchase 2,473,334 Shares of Common Stock.
6 days ago
Aptevo Therapeutics Stockholders Approve Reverse Split - TipRanks.com
Tipranks
Aptevo Therapeutics Inc (APVO) has released an update to notify the public and investors about the submission of matters to a vote of security holders.
2 months ago
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why
Yahoo Finance
Aptevo Therapeutics APVO is a clinical-stage pharmaceutical company focused on developing novel therapies targeting cancer indications.
2 days ago
Aptevo Therapeutics sets terms for $4.6 million public offering
Investing.com
SEATTLE - Aptevo Therapeutics Inc . (NASDAQ:APVO), a biotechnology firm engaged in developing cancer treatments, has announced the pricing...
1 week ago
Aptevo Therapeutics prices 3.4M shares at $1.35 in public offering - TipRanks.com
Tipranks
Aptevo Therapeutics announced the pricing of a public offering of 3400000 shares of its common stock or pre-funded warrants in lieu thereof...
6 days ago
Aptevo Therapeutics enacts reverse stock split to meet Nasdaq requirements
Investing.com
(NASDAQ:APVO), a clinical-stage biotech company, announced today a reverse stock split of its common stock at a ratio of 1-for-44, to be...
1 month ago
Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Large Increase in Short Interest
Defense World
Read Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Large Increase in Short Interest at Defense World.
5 days ago